Search I95 Business Magazine




Advances in Radiation Oncology
The Kaufman Cancer Center at University of Maryland Upper Chesapeake Medical Center

October 2016
The Radiation Oncology Team at the Kaufman Cancer Center

The Radiation Oncology Team at the Kaufman Cancer Center

At some point during cancer treatment, nearly two-thirds of patients will receive radiation therapy, either alone or combined with chemotherapy or surgery. Traditional radiation therapy is delivered in small daily doses over the course of several weeks. But due to exciting advancements in technology, the level of precision with which a tumor can be treated by radiation has increased dramatically. Newer stereotactic (more accurate) treatment delivery methods can take much less time, as concentrated high-dose radiation is delivered directly to the tumor with extreme precision. Even very tiny tumors can be treated with much less damage to the surrounding normal tissue, causing fewer side effects for patients.

The Kaufman Cancer Center at University of Maryland Upper Chesapeake Medical Center
The radiation oncology program at the Kaufman Cancer Center (KCC) is directed by highly trained experts from the University of Maryland Department of Radiation Oncology. These specialists have actually helped develop much of the technology used in the Center, allowing our team to handle even the most advanced or complex cases. We have some of the best equipment available anywhere and the expertise to use it.

Our experts work as part of a multidisciplinary team, along with medical, surgical and other oncology specialists to deliver a comprehensive and customized treatment plan for every patient. A treatment plan that includes the most advanced radiation therapies using state-of-the-art technology. This coordinated team approach to cancer care gives individuals access to the widest possible range of treatment options and the best chance for a successful outcome.

Our Technology
TrueBeam™ and Trilogy® Linear Accelerators – radiation therapy machines that deliver treatment with sub-millimeter accuracy in a straight line, directly to the tumor and, in some cases, up to 50 percent faster than earlier systems.

RapidArc® – an advanced form of radiation therapy that distributes treatment in a 360-degree rotation so that the tumor can be attacked in a complete three-dimensional manner.

Tumor Treating Fields (TTF) – TTF is used for recurrent glioblastoma (a form of brain cancer). Treatment is delivered to the patient through a device that fits on the scalp and works by emitting alternating electrical fields to the tumor that disrupt the division of cancer cells and stop tumor growth.

Calypso® 4D Localization System™ – Also known as GPS for the Body®, this technology is used in the treatment of prostate cancer. It consists of electromagnetic sensors implanted in a patient that transmit information ten times per second, and concentrate radiation to the exact location of the tumor.

Our Leaders
HongJack Hong, MD is the medical director of the radiation oncology program at the Kaufman Cancer Center. He oversees the robust clinical program that offers cutting edge technologies inclusive of brachytherapy (placing radioactive material inside the body, sometimes called internal radiation) and stereotactic radiation services. Dr. Hong works in collaboration with the University of Maryland Greenebaum Cancer Center to promote and grow radiation oncology-based clinical trials and research protocols. He is experienced in the latest radiation modalities and is considered a regional expert in the use of brachytherapy.

MishraMark Mishra, MD leads the development of radiation oncology clinical trials and research programs at University of Maryland Upper Chesapeake Health. He is an assistant professor of radiation oncology at the University of Maryland School of Medicine. One of his main areas of interest is clinical effectiveness research, which he focuses on at both the Kaufman Cancer Center and the University of Maryland Medical Center. I95